We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Andor Tech | LSE:AND | London | Ordinary Share | GB00B043J741 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 509.75 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
02/6/2013 08:56 | a few sells triggered some stop losses | robow | |
01/6/2013 15:15 | Anyone know why this dropped from 357p to 310p during Friday? Worrying. | proj | |
01/6/2013 14:23 | big write up on Andor in tipsheet small company share watch. Their pick of the month. Will open higher on Monday. | craffert | |
24/4/2013 14:29 | ... so that's what it is all about. | piedro | |
24/4/2013 14:23 | 2013 Insight Awards Winners Announced Andor helps Researchers show the artistic side of science Belfast, 24 April, 2013 Andor Technology plc (Andor), a world leader in scientific imaging and spectroscopy solutions, today announced that three visually stunning and scientifically captivating entries have won their categories in the Andor Insight Awards Scientific Imaging Competition. Stephen DeCamp of Brandeis University topped the Physical Sciences category; Fernando Amat of the Howard Hughes Medical Institute came top in the Life Sciences category; and Jamie Kasuboski of The Waitt Advanced Biophotonics Center Core at The Salk Institute for Biological Studies won in the Imaris category. Stephen DeCamp's entry is entitled 'Oscillating Microtubule Bundles' and investigates the material properties of mixtures of microtubules, a depletion agent and the molecular motor Kinesin. Acquired using an Andor Clara CCD camera, the short movie shows a method that will allow scientists to study systems of self-propelled and self-organized matter that exist in the field known as Active Matter. Fernando Amat entered a video entitled 'Global nuclei tracking in the Drosophila syncytial blastoderm', which captures part of the mitotic cycle in a Drosophila embryo. This technique allows rendering and tracking of cell components with an efficiency of over 95%. It was captured using a multi-view light-sheet microscope equipped with two Andor Neo sCMOS cameras. Jamie Kasuboski's entry entitled 'Whole Mouse Brain 3D Reconstruction' shows, in incredible detail, an Imaris 3D reconstruction of a mouse brain including proteins and neuron structure. Later analysis counted which regions of the brain contained specific cell types, therefore giving a powerful insight in to the wiring of the brain. The winners were selected from a panel of expert judges from both life and physical sciences that included: Dr. Bob Marshall of Stanford University, Dr. Satoshi Nishimura of the University of Tokyo, Dr. Gábor Csúcs of the Institute for Biochemistry in Zürich and Dr. Donal Denvir from Andor Technology. The Insight Awards focus on recognising the cutting edge work carried out by researchers using Andor equipment or Bitplane software in the fields of Physical and Life Sciences Imaging. This year's entries utilised the full spectrum of Andor and Bitplane products including spectrographs, EMCCD and sCMOS cameras, Confocal Microscopy Systems and Imaris® software. "The visual impact and scientific value of this year's entries clearly highlights the cutting edge work being carried out by researchers using our products" said Dr. Andrew Dennis, Director of Product Management. "The judge's selection of winners provides an interesting insight into the significance and detail of the researcher's work across multiple scientific disciplines." | piedro | |
16/4/2013 09:58 | More about brains - using Imaris Transparent Brains Reveal Hidden Microscopic Details | piedro | |
11/4/2013 15:52 | Imaris in the NY Times ... Brains as Clear as Jell-O for Scientists to Explore The hippocampus region showing molecular labeling with antibodies in clarified mouse brain. Shown are networks of two types of neurons, shown in red and green, and non-neuronal glial cells, shown in blue. The video first shows a series of images through the three-dimensional reconstruction and then a full rendering. .... | piedro | |
03/4/2013 15:18 | Beginning to become a trend imv, following years of fantastic growth. | essentialinvestor | |
03/4/2013 13:36 | Piedro:> Thanks for your data. Most useful. Was on my watch list but your interpretation (which is -imo- spot on - means it will stay on the watch list. Memo to self - Keep finger away from the buy button. !!! | pugugly | |
03/4/2013 12:39 | Research analysts at Investec increased their target price on shares of Andor Technology (LON: AND) from $7.60 (500 GBX) to $7.98 (525 GBX) in a report released on Wednesday, Stock Ratings Network reports. The firm currently has a "buy" rating on the stock. -- Piedro - you are probably right. | dasv | |
03/4/2013 09:40 | Explains the Trading update statements ... - We however remain focused on initiatives to deliver growth over the longer term. - We have invested for growth in our facility and have capacity that can be readily leveraged when required. - Finally, we have increased our search for strategic acquisition opportunities to further grow our business. As a result, we remain positive about our future. ... going ex-growth and under capacity facility. ... an acquisition is urgently needed to keep up the momentum ... but nothing sighted as yet - AIMO | piedro | |
03/4/2013 09:26 | daddy13, Thank you for the link Andor Technology (AND) Trading Update - This morning Andor Technology has released a trading update for H1 2013. Essentially the year is proving to be a bit more challenging than we had hoped. - Although we expected H1 to get off to a relatively slow start it is proving to be a little weaker than we expected. Combined with a rising fixed cost base to enable the company to take advantage of future growth opportunities, we are now forced to slightly reduce our forecasts for the year. - H1 revenue is likely to be between £27m £28m, slightly better than H2 2012, but about 10% down on H1 2012. While weakness in EMEA and Americas was expected, the incremental softness versus our original expectations is in Japan. - We are trimming our 2013FY revenue estimate to £60m (was £62.4m) which is still growth y-o-y, but only 3%. - We now expect adjusted pre-tax Profit and adjusted Earnings to be flat y-o-y at £10m and 25.3p respectively. This is a downgrade of a little less than 10%. - We believe this downgrade reflects well known macro-economic issues around the world and in no way shakes our confidence in Andor. We continue to believe its market leading positions and new product launches will drive growth going forward. - We expect the company to remain strongly cash generative. - The shares trade at 15x 2013E earnings, 8.8x EBITDA and have a free cash yield of 6.6%. | piedro | |
08/3/2013 12:13 | Noticed this morning that I sold a tranche of these last July @ 386. Nothing is happening so I've sold the rest and am taking a position in OXA. GLA. | yachtie8078 | |
26/2/2013 09:35 | That was a trading statement and ... .... Furthermore, trading has continued at levels similar to those experienced in the second six months of the last financial year, and we expect this trend to continue for the remainder of the first half. A reminder of H2-12 | piedro | |
26/2/2013 08:59 | Nice to see a break above 400 after positivehalf yearly report particularly on a massive down-day on the wider market. | dasv | |
07/2/2013 15:17 | thanks for that Wexboy, interesting read. | alter ego | |
07/2/2013 14:21 | 2013 The Great Irish Share Valuation Project (Part III) I take a look at Andor Technology, plus a batch of other Irish stocks: Cheers, Wexboy | wexboy | |
11/1/2013 12:07 | The share has been very kind to me - I bought £10k @207p back in 2010 and have topsliced 3 times! Now wanting one last push up so I can cash the rest in. So sorry Piedro, one big push please lads!! GL guys. | yachtie8078 | |
08/1/2013 17:19 | As you say, it rather depends on whether you already hold or not. A p/e of 14-15 doesn't strike me as rich given the growth record, even if the year ahead is expected to be more muted. | alter ego | |
08/1/2013 14:23 | errhh ... !!! I have a slight problem .... I want the share price to go down to pick up some more Seems too expensive atm - please correct me if I am wrong. P. | piedro | |
08/1/2013 12:45 | yes, well done Piedro, let's also hope that the share price goes into orbit. | alter ego | |
08/1/2013 12:33 | Piedro - nice find, let's hope we start to gain traction - it's all too quiet!! | yachtie8078 | |
08/1/2013 11:29 | Article in the Guardian re ... The Next-Generation Transit Survey (NGTS) is a wide-field photometric survey designed to discover transiting exoplanets of Neptune-size and smaller around bright stars .... NGTS employs an array of fully-robotic small telescopes operating in the 600-900nm band, thereby maximizing sensitivity to bright but relatively small host stars (K and early-M spectral type). .... The optical system is designed to observe with optimal sensitivity in the 600 to 900nm range, in order to match the peak emission of the primary targets (K and early M). Large format (2k×2k) CCD cameras have been developed by our industrial partners (Andor Technology, Belfast, and e2v, Chelmsford) specifically for our requirements, and these have now been made commercially available in their product line. ... | piedro |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions